Grant Private Wealth Management Inc Takes Position in Intuitive Surgical, Inc. $ISRG

Grant Private Wealth Management Inc bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 3,652 shares of the medical equipment provider’s stock, valued at approximately $1,633,000. Intuitive Surgical comprises about 1.0% of Grant Private Wealth Management Inc’s holdings, making the stock its 25th largest position.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Brighton Jones LLC lifted its stake in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Steward Partners Investment Advisory LLC increased its holdings in Intuitive Surgical by 17.6% in the first quarter. Steward Partners Investment Advisory LLC now owns 17,087 shares of the medical equipment provider’s stock worth $8,463,000 after purchasing an additional 2,562 shares in the last quarter. RWA Wealth Partners LLC lifted its stake in Intuitive Surgical by 3.6% in the first quarter. RWA Wealth Partners LLC now owns 7,918 shares of the medical equipment provider’s stock valued at $3,922,000 after buying an additional 275 shares during the period. BSN CAPITAL PARTNERS Ltd bought a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $43,088,000. Finally, Colonial Trust Advisors grew its position in shares of Intuitive Surgical by 5,000.0% during the 1st quarter. Colonial Trust Advisors now owns 102 shares of the medical equipment provider’s stock worth $51,000 after buying an additional 100 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the transaction, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at $128,266,872.80. The trade was a 9.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the sale, the executive vice president owned 353 shares of the company’s stock, valued at approximately $193,595.79. The trade was a 95.54% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 114,007 shares of company stock valued at $63,533,844 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Rothschild & Co Redburn boosted their target price on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Argus increased their price objective on shares of Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, The Goldman Sachs Group upped their price target on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $608.79.

Intuitive Surgical Price Performance

ISRG opened at $554.58 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a market capitalization of $198.81 billion, a PE ratio of 73.36, a P/E/G ratio of 5.14 and a beta of 1.68. The company’s 50-day moving average is $534.09 and its 200 day moving average is $505.41.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.84 EPS. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.